Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human LEPREL1 ELISA Kit (AC3087)
Cat.#: ASET-1676
Specifications
Description Human LEPREL1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human LEPREL1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.22 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 200-3200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1109 Human SNPH ELISA Kit (AC2520) Quantitative inquiry ASET-1141 Human Dio3 ELISA Kit (AC2552) Quantitative inquiry ASET-1838 Human LST1 ELISA Kit (AC3249) Quantitative inquiry ASET-1664 Mouse BMAL1 ELISA Kit (AC3075) Quantitative inquiry ASET-2415 Mouse Substance P ELISA Kit (AC3826) Quantitative inquiry ASET-1399 Mouse alpha 2a Adrenergic Receptor ELISA Kit (AC2810) Quantitative inquiry ASET-1435 Monkey Heme Oxygenase 1 ELISA Kit (AC2846) Quantitative inquiry ASET-1764 Human NRG1 ELISA Kit (AC3175) Quantitative inquiry ASET-2089 Chicken CNTF ELISA Kit (AC3500) Quantitative inquiry ASET-1271 Human Nestin ELISA Kit (AC2682) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket